Sign in to follow
Search Results

0 results for 'Regeneron Pharmaceuticals'

You can use to get even better search results
August 27, 2024 | New York Law Journal

In-House Impact Finalist: Regeneron

"Lawyers should seize opportunities to broaden their experiences by venturing into diverse areas, stepping beyond their comfort zones."
3 minute read
August 20, 2024 | Corporate Counsel

Corporate Counsel Announces Finalists for the 2024 Best Legal Department Awards

Corporate Counsel's editorial department is pleased to announce the finalists of our 2024 Best Legal Departments awards. We have selected outstanding corporate legal departments and legal leaders that stood out this past year.
2 minute read
March 01, 2024 | New York Law Journal

The Future of Pay Frequency Litigation in NY: A 'Grant' to Employers?

Since the authors' previous New York Law Journal article, there has been a significant change in the legal landscape in the area of pay frequency. The change has the potential to stem the tide of pay frequency litigation.
9 minute read
October 04, 2023 | Law.com

Feds' False Claims Act Lawsuit Against Regeneron Gets Partial Go-Ahead for Trial

"The government, like any litigant, is entitled to attempt to prove its case through circumstantial evidence and reasonable inferences," the U.S. District Court for the District of Massachusetts ruled.
6 minute read
May 22, 2023 | The Legal Intelligencer

Is Change Coming? Enablement Requirement of Functional Genus Claims After 'Sanofi'

The Supreme Court upheld both the district court's and the federal circuit's decisions that Amgen's patent claims at issue do not provide sufficient details to enable the full scope of its claimed invention and thus are invalid.
6 minute read
Law Journal Press | Digital Book Bucks County Court Rules 2024 Authors: View this Book

View more book results for the query "Regeneron Pharmaceuticals"

May 01, 2023 | Law.com

Federal Judge Nixes Regeneron's Request for Additional Discovery in False Claims Act Suit

"Under the circumstances, the court can see little benefit in permitting additional discovery, and without question the burden and expense of continued discovery greatly outweigh any likely benefit to be gained thereby," wrote Judge F. Dennis Saylor IV for the District Court of Massachusetts.
6 minute read
March 27, 2023 | Supreme Court Brief

Supreme Court Brief: Who's at the Lectern | Oral Argument Previews

The justices are set to hear a dispute over cholesterol medication patents alleging that recent changes to patent law have created an undue disclosure burden on creators.
9 minute read
March 24, 2023 | National Law Journal

Why the Supreme Court Should Reject Attempts to Monopolize a Therapeutic Target

Patents that lay claim to all antibody therapeutics for a biological target stifle medical innovation and hurt patients.
5 minute read
November 29, 2022 | The American Lawyer

Nearly $10 Trillion in Deals: A Closer Look at the Law Firm Corporate Practices of the Year Finalists

These six firms aided clients in staggering growth over the past two years.
8 minute read
June 01, 2022 | Delaware Business Court Insider

Pharma Co. Hit With Antitrust Suit for Allegedly Blocking Sale of Competitor's Cholesterol Med

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • 2024 Trends Report Mid-Year Special Edition: Update on Outside Counsel Billing Rates

    Brought to you by LexisNexis® CounselLink®

    Download Now

  • AI in Private Equity: A Guide for Gaining an Early Advantage

    Brought to you by Ontra

    Download Now

  • Why Are So Many Law Firms Suddenly Embracing Digital Transformation?

    Brought to you by AllRize

    Download Now

  • 2025 State Legislative Sessions

    Brought to you by LexisNexis®

    Download Now